Nephron recalls sterile injections with potential contamination risk. Products may cause infection if used. Contact for details.
Lack of Assurance of Sterility
Nephron is recalling certain injections of ropivacaine, clonidine, and ketorolac due to a lack of assurance of sterility. This means the products could be contaminated and cause infections if used.
The injections may not be sterile, which can lead to infections in patients. This is a risk during medical procedures where the product is injected into the body.
Healthcare professionals who use these injections for medical procedures. Patients receiving these injections are at risk of infection if the product is contaminated.
Check for the NDC code 69374-515-50 on the packaging. Products were made in batches RP2003A and RP2003B, expiring July 20, 2022.
Look for the NDC code 69374-515-50 and batch numbers RP2003A or RP2003B on the packaging.
The recall states there is a lack of assurance of sterility, meaning the product could be contaminated and cause infections. Do not use these products.
The recall does not specify a remedy, so contact Nephron directly for guidance.
The products were made in batches RP2003A and RP2003B, expiring July 20, 2022.
We’ve drafted a message you can send Nephron to request your refund or repair — edit it as you like.
Subject: Recall D-1278-2022 — Nephron Nephron Hello, I own a Nephron that is covered by recall D-1278-2022 from Nephron. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
